1988–1993: M.Sc. in Pharmacy (cum laude), University of Groningen, the Netherlands
1993–1998: Ph.D. in Medicinal Chemistry (cum laude), University of Groningen, the Netherlands
1998–1999: Postdoctoral Fellowship at Pharmacopeia, Inc., Princeton, New Jersey, USA
1999–2000: Computational Chemist at Pharmacopeia, Inc., Princeton, New Jersey, USA
2001–2008: Computational Chemist at Biovitrum, Stockholm, Sweden
2008–2010: Senior Computational Chemist at Beactica, Uppsala, Sweden
2000–2001: Computational Chemist at Pharmacia Corporation, Stockholm, Sweden
2010–2013: Chief Operating Officer at Beactica, Uppsala, Sweden
2013–present: Senior Researcher, Computational Chemistry at SciLifeLab, Stockholm, Sweden
In my free time I like to go ice skating, listen to 80’s rock music, play with computers, and relax at my summer house with my family.
Published at Helleday Laboratory
Hypoxic signaling and the cellular redox tumor environment determine sensitivity to MTH1 inhibition Journal Article
Cancer Res., 2016, ([DOI:hrefhttp://dx.doi.org/10.1158/0008-5472.CAN-15-238010.1158/0008-5472.CAN-15-2380] [PubMed:hrefhttp://www.ncbi.nlm.nih.gov/pubmed/2686211426862114]).